Axsome Therapeutics (AXSM) Q2 2024 Earnings Call Transcript

By Yahoo! Finance | Aug 5, 2024 at 01:45 PM EST

During the Axsome Therapeutics Q2 2024 financial results conference call, they highlighted strong commercial performance and pipeline advancements. Key upcoming milestones include results from phase 3 trials for AXS-05 and solriamfetol in various indications.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.